The global pandemic of novel coronavirus disease 2019 (COVID‐19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has created an urgent need for …

Introduction Because of the high mortality of invasive fungal infections (IFIs), appropriate
exposure to antifungals appears to be crucial for therapeutic efficacy and safety. Materials …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

On May 1, 2020, after review of yet unpublished data from available clinical trials, the US
Food and Drug Administration issued an emergency use authorization (EUA) to permit the …

Highlights•Cyclodextrins and the complexes they form are described.•Pharmaceutical uses
of cyclodextrin are enumerated.•Physical chemical properties of cyclodextrins are …

Posaconazole is typically used for preventing invasive yeast and mold infections such as
invasive aspergillosis in high-risk immunocompromised patients. The oral suspension was …

Continuous Renal Replacement Therapy (CRRT) is more and more widely used in patients
for various indications recent years. It is still intricate for clinicians to decide a suitable …

Abstract Background Remdesivir (RDV) is US FDA approved for coronavirus disease 2019
(COVID-19) but not recommended in severe renal impairment (SRI, Creatinine clearance< …

Objective: To review the safety and efficacy of brexanolone for the treatment of moderate to
severe postpartum depression (PPD). Data Sources: A literature search through PubMed …

Remdesivir was recently approved by the Food and Drug Administration for the treatment of
hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is the prodrug …